For condition: Vitiligo
The Proof-of-Concept Vitiligo Research Study (48 Weeks)
Study Summary
Who Can Participate?
Adults 18 to under 75 years of age who have non-segmental vitiligo (NSV), may be eligible.
Inclusion Criteria:
-
- Have the following at both screening and baseline:
- a clinical diagnosis of NSV for at least 3 months
- depigmentation involvement of 4% to 60% on the body (excluding the palms of the hands and soles or dorsal aspect of the feet)
- depigmentation involvement of 0.5% or more on the face
- either active or stable disease
- Agree not to use any treatments for vitiligo during the study, through the final follow-up visit
Study Details:
-
- Participants will have regular visits with study doctors who are specialized in treating NSV
- Blood and/or urine samples will be collected for evaluation at specified time-points
- Participants will receive investigational IV infusion medication (active study drug) or placebo
- Reimbursement for study-related expenses may be provided
How Long Will the Study Last?
-
- Participation will last about 48 weeks and involve about 9 visits to the study research site
General Info:
-
- Completing a registration form does not mean that you will enter the study; other eligibility criteria may apply
- Once you fill out a registration form you will be contacted by RT.com to collect additional information
- Should you no longer wish to participate in the study, you may withdraw your consent at any time
- There is no cost to participate or receive study medication
For more information about this trial, please visit ClinicalTrials.gov
